C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 215/40 (2006.01) A61K 31/40 (2006.01) A61K 31/47 (2006.01) A61K 31/535 (2006.01) C07C 275/28 (2006.01) C07D 209/48 (2006.01) C07D 213/75 (2006.01) C07D 215/38 (2006.01) C07D 217/22 (2006.01) C07D 241/42 (2006.01) C07D 241/44 (2006.01) C07D 265/36 (2006.01) C07D 279/16 (2006.01) C07D 401/12 (2006.01) C07D 403/12 (2006.01) C07K 5/06 (2006.01) A61K 38/00 (2006.01)
Patent
CA 2074357
Compounds of formula (I) in which R1 is an optionally substituted phenyl radical or a -CH(R4)-CO-R5 chain, R2 is a pyridyl, isoquinolyl, quinolyl, quinoxalinyl, alkyl, phenylalkyl, naphthyl, tetrahydro-5,6,7,8 naphthyl, tetrahydro-1,2,3,4 naphthyl, alkoxycarbonylalkyl or cycloalkylradical, R3 is an optionally substituted phenyl, naphthyl, indolyl, quinolyl or optionally substituted phenylamino radical, processes for their preparation and medicaments containing them.
BREVET D'INVENTION DERIVES DE GLYCINAMIDE LEUR PREPARATION ET LES MEDICAMENTS LES CONTENANT. RHONE - POULENC RORER S. A. ABREGE Composés de formule : Image (I) dans laquelle R1 représente un radical phényle éventuellement substitué ou une chaîne -CH(R4)-CO-R5, R2 représente un radical pyridyle, isoquinolyle, quinolyle, quinoxalinyl, alkyle, phénylalkyle, naphtyle, tétrahydro-5,6,7,8 naphthyle, tétrahydro-1,2,3,4 naphtyle, alcoxycarbonylalkyle ou cycloalkyle, R3 représente un radical phényle éventuellement substitué, naphtyle, indolyle, quinolyle ou phénylamino éventuellement substitué, leurs procédés de préparation et les médicaments les contenant.
Bourzat Jean-Dominique
Capet Marc
Cotrel Claude
Guyon Claude
Manfre Franco
Rhone-Poulenc Rorer S.a.
Robic
LandOfFree
Glucinamid derivatives, their preparation and drugs... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Glucinamid derivatives, their preparation and drugs..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Glucinamid derivatives, their preparation and drugs... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1770922